2.265USD-0.22%Mkt Cap: 142.66M USDP/E: —Last update: 2026-06-01
TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company's lead product candidate includes IFx2.0, an innate immune ago…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap142.66M USD
Enterprise Value138.36M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-30.05M USD
Revenue/Share—
Last Price2.265 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees22
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.90
PEG—
EV/EBITDA-4.78
EV/Revenue—
P/S—
P/B6.49
EPS (TTM)-0.61
EPS (Forward)-0.58
52W Range
0.410053% of range3.900
52W High3.900 USD
52W Low0.4100 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-143.57%
ROA-109.87%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-27.63M USD
CapEx (TTM)76.08K USD
FCF Margin—
FCF Yield-1.14%
Net Debt-5.84M USD
Net Debt/EBITDA0.20
Balance Sheet
Debt/Equity0.03
Current Ratio1.15
Quick Ratio1.07
Book Value/Sh0.3480 USD
Cash/Share0.0990 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:35
Split DateOct 18, 2024
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)8.040 USD
Target Range6.200 USD – 10.00 USD
# Analysts5
Ownership
Shares Out.63.68M
Float35.44M
Insiders34.88%
Institutions14.98%
Short Interest
Short Ratio9.1d
Short % Float16.26%
Short % Out.12.54%
Shares Short7.98M
Short (prev mo.)8.32M
Technical
SMA 502.262 (+0.1%)
SMA 2001.928 (+17.5%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)681.60K
Avg Vol (10d)567.68K
Technical Indicators
RSI (14)46.5
MACD0.0219
MACD Signal0.0485
MACD Hist.-0.0266
BB Upper2.601 USD
BB Middle2.398 USD
BB Lower2.195 USD
BB Width16.94%
ATR (14)0.2253 USD
Vol Ratio (20d)0.56x